These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14597992)

  • 1. Ultrasound screening for distal vein thrombosis is not beneficial after major orthopedic surgery. A randomized controlled trial.
    Schmidt B; Michler R; Klein M; Faulmann G; Weber C; Schellong S
    Thromb Haemost; 2003 Nov; 90(5):949-54. PubMed ID: 14597992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].
    Barrellier MT; Samama CM
    J Mal Vasc; 2013 May; 38(3):178-84. PubMed ID: 23415379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of deep venous thrombosis in patients admitted to rehabilitation clinics after major orthopaedic surgery.
    Beyer-Westendorf J; Bogorad V; Tautenhahn I; Marten S; Schellong S
    Vasa; 2013 Jan; 42(1):40-9. PubMed ID: 23385225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis.
    Singh K; Yakoub D; Giangola P; DeCicca M; Patel CA; Marzouk F; Giangola G
    J Vasc Surg; 2012 Jan; 55(1):136-40. PubMed ID: 21982332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of extended thrombo-prophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis.
    Bottaro FJ; Elizondo MC; Doti C; Bruetman JE; Perez Moreno PD; Bullorsky EO; Ceresetto JM
    Thromb Haemost; 2008 Jun; 99(6):1104-11. PubMed ID: 18521515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
    Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.
    Park WJ; Jo SH; Kim SA; Kim HS; Han SJ; Choi YJ; Rhim CY
    Contemp Clin Trials; 2011 Sep; 32(5):779-82. PubMed ID: 21684353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and countermeasures for venous thromboembolic diseases associated with spinal surgery: a follow-up study of an institutional protocol in 209 patients.
    Akeda K; Matsunaga H; Imanishi T; Hasegawa M; Sakakibara T; Kasai Y; Sudo A
    Spine (Phila Pa 1976); 2014 May; 39(10):791-7. PubMed ID: 24583727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement.
    Manganelli D; Pazzagli M; Mazzantini D; Punzi G; Manca M; Vignali C; Palla A; Troiani R; Rossi G
    Respiration; 1998; 65(5):369-74. PubMed ID: 9782219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic patients at high risk for deep venous thrombosis who receive inadequate prophylaxis should be screened.
    Estrada CA; McElligott J; Dolezal JM; Cunningham PR
    South Med J; 1999 Dec; 92(12):1145-50. PubMed ID: 10624903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.